CLINICAL_TRIALS
trial_result
· 2016-07-22
Clinical Trial Update: A Study of Subcutaneous Mircera for the Maintenance Treatment of Participants With Chronic Renal Anemia [Phase 4]
Summary
Phase 4 trial results update for subcutaneous Mircera used as maintenance therapy in anemia of chronic kidney disease; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 4 | Status: COMPLETED | Results posted: 2016-07-22